PL448469A1 - Przedmiotem wynalazku jest sposób wzbogacania preparatów plazmy krwi drobiowej w immunoglobulinę G (IgG) - Google Patents
Przedmiotem wynalazku jest sposób wzbogacania preparatów plazmy krwi drobiowej w immunoglobulinę G (IgG)Info
- Publication number
- PL448469A1 PL448469A1 PL448469A PL44846924A PL448469A1 PL 448469 A1 PL448469 A1 PL 448469A1 PL 448469 A PL448469 A PL 448469A PL 44846924 A PL44846924 A PL 44846924A PL 448469 A1 PL448469 A1 PL 448469A1
- Authority
- PL
- Poland
- Prior art keywords
- igg
- enriching
- blood plasma
- immunoglobulin
- poultry blood
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Przedmiotem zgłoszenia jest sposób wzbogacenia plazmy krwi drobiu w immunoglobulinę IgG polegający na wysalaniu białek, w roztworach NaCl, które następnie sedymentują w formie osadu w dolnej części zbiornika, a oddzielana jest część górna zasolonej plazmy ze zbiornika. Pozostała frakcja z osadem wysolonych białek zostaje rozrzedzona poprzez dodanie części wody, co powoduje rozpuszczenie IgG w wyniku obniżenia stężenia soli poniżej 6% wag. NaCl oraz zagęszczana techniką filtracji membranowej i odsalana poprzez dodawanie wody i kolejne zagęszczania (diafiltracja).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL448469A PL448469A1 (pl) | 2024-04-30 | 2024-04-30 | Przedmiotem wynalazku jest sposób wzbogacania preparatów plazmy krwi drobiowej w immunoglobulinę G (IgG) |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL448469A PL448469A1 (pl) | 2024-04-30 | 2024-04-30 | Przedmiotem wynalazku jest sposób wzbogacania preparatów plazmy krwi drobiowej w immunoglobulinę G (IgG) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL448469A1 true PL448469A1 (pl) | 2025-11-03 |
Family
ID=97522422
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL448469A PL448469A1 (pl) | 2024-04-30 | 2024-04-30 | Przedmiotem wynalazku jest sposób wzbogacania preparatów plazmy krwi drobiowej w immunoglobulinę G (IgG) |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL448469A1 (pl) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0123029A1 (de) * | 1983-03-21 | 1984-10-31 | Heilmittelwerke Wien Gesellschaft m.b.H. | Verfahren zur Herstellung einer nebenwirkungsfreien IgG-Immunglobulinlösung für die intravenöse Applikation |
| US4880913A (en) * | 1986-12-02 | 1989-11-14 | Schwab & Co. Ges.M.B.H. | Process for the preparation of an immunoglobulin which can be administered intravenously and is stable in liquid form |
| WO2011149472A1 (en) * | 2010-05-26 | 2011-12-01 | Baxter International Inc. | Method for preparing an enriched igg composition from plasma |
| WO2016088135A1 (en) * | 2014-12-02 | 2016-06-09 | Hemarus Therapeutics Ltd. | A process for increased yield of immunoglobulin from human plasma |
| WO2017078947A1 (en) * | 2015-10-21 | 2017-05-11 | Cambryn Biologics, Llc | Processes for purifying proteins from plasma |
| WO2021202373A1 (en) * | 2020-03-31 | 2021-10-07 | Baxalta Incorporated | A method to produce an immunoglobulin preparation from c-1 inhibitor depleted plasma |
-
2024
- 2024-04-30 PL PL448469A patent/PL448469A1/pl unknown
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0123029A1 (de) * | 1983-03-21 | 1984-10-31 | Heilmittelwerke Wien Gesellschaft m.b.H. | Verfahren zur Herstellung einer nebenwirkungsfreien IgG-Immunglobulinlösung für die intravenöse Applikation |
| US4880913A (en) * | 1986-12-02 | 1989-11-14 | Schwab & Co. Ges.M.B.H. | Process for the preparation of an immunoglobulin which can be administered intravenously and is stable in liquid form |
| WO2011149472A1 (en) * | 2010-05-26 | 2011-12-01 | Baxter International Inc. | Method for preparing an enriched igg composition from plasma |
| WO2016088135A1 (en) * | 2014-12-02 | 2016-06-09 | Hemarus Therapeutics Ltd. | A process for increased yield of immunoglobulin from human plasma |
| WO2017078947A1 (en) * | 2015-10-21 | 2017-05-11 | Cambryn Biologics, Llc | Processes for purifying proteins from plasma |
| WO2021202373A1 (en) * | 2020-03-31 | 2021-10-07 | Baxalta Incorporated | A method to produce an immunoglobulin preparation from c-1 inhibitor depleted plasma |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Andrews et al. | Low-density lipoproteins inhibit endothelium-dependent relaxation in rabbit aorta | |
| JP4476362B2 (ja) | 生物学的に活性なペプチドのミルクからの精製 | |
| Deves et al. | Transporters for cationic amino acids in animal cells: discovery, structure, and function | |
| Tanphaichitr et al. | Novel AE1 mutations in recessive distal renal tubular acidosis. Loss-of-function is rescued by glycophorin A. | |
| AU2007266951C1 (en) | Method for the extraction of one or several proteins present in milk | |
| Takahashi et al. | Occurrence of anti-gizzard P34K antibody cross-reactive components in bovine smooth muscles and non-smooth muscle tissues | |
| Kimura et al. | Characterization and localization of α-connectin (titin 1): an elastic protein isolated from rabbit skeletal muscle | |
| PL448469A1 (pl) | Przedmiotem wynalazku jest sposób wzbogacania preparatów plazmy krwi drobiowej w immunoglobulinę G (IgG) | |
| Osawa et al. | Ribonucleic acid and protein in the growing oocytes of Triturus pyrrhogaster | |
| Walters et al. | Stimulation of intestinal basolateral membrane calcium-pump activity by recombinant synthetic calbindin-D9k and specific mutants | |
| EP3653721A1 (en) | Method and composition for hydrolyzing eggshell membrane | |
| Vater et al. | Purification and characterization of a cortical secretory vesicle membrane fraction | |
| GASKA et al. | Timed emulsification studies with chicken breast muscle: whole muscle, low‐salt washed muscle and low‐salt soluble proteins | |
| RU2672105C2 (ru) | Способы получения нового поколения безопасных с биологической точки зрения продуктов klh, применяемых для лечения рака, для разработки конъюгированных терапевтических вакцин и в качестве стимулирующих средств | |
| Gade et al. | A brief survey of aquaporins and their implications for renal physiology | |
| RU2681413C2 (ru) | Способы получения нового поколения безопасных с биологической точки зрения продуктов klh, применяемых для лечения рака, для разработки коньюгированных терапевтических вакцин и в качестве стимулирующих средств | |
| Turhan et al. | Fractionation of caseins by anion‐exchange chromatography using food‐grade buffers | |
| AU2021104426A4 (en) | Method for successively extracting multiple proteins from egg white | |
| JPH04189832A (ja) | ケラチンのミセル水溶液の製造法 | |
| JPH06116297A (ja) | 卵黄水溶性蛋白質の分離方法 | |
| Grover et al. | Ca PUMPS IN RABBIT STOMACH SMOOTH MUSCLE PLASMA MEMBRANE AND ENDOPLASMIC RETICULUM | |
| Riddick | Copper dependent defects in mitochondria | |
| Bre'Ida | Copper Dependent Defects in Mitochondria | |
| Umemura et al. | Risk factors for chronic kidney disease after pediatric liver transplantation | |
| RU2000123226A (ru) | Способ получения иммуноглобулинового препарата |